tm logo
XIROMED
Live/Registered
REGISTERED

on 28 Dec 2021

Last Applicant/ Owned by

3rd and 4th floors

MADRID

ES

28050

Serial Number

87091052 filed on 01st Jul 2016

Registration Number

6603289 registered on 28th Dec 2021

in the Principal Register

Correspondent Address

Arturo Perez-Guerrero

MARCAS ESTADOS UNIDOS / PEREZ GUERRERO L

P.O. Box 9024163

San Juan, PR 00902-4163

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

XIROMED

The mark consists of the words "XIROMED" in stylized capital letters, the color blue appears in the upper section of the letter "X" and the color gray appears in the lower section of the letter "X" and in the letters "IROMED". Pharmaceutical preparation for use in treating digestive diseases and disorders, gynecological diseases and disorders, hormonal diseases and disorders, blood disorders, canRead More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparation for use in treating digestive diseases and disorders, gynecological diseases and disorders, hormonal diseases and disorders, blood disorders, cancer, cardiovascular diseases, vascular diseases, gastrointestinal diseases, genitourinary diseases, immunologic diseases, infectious diseases, inflammatory diseases, metabolic diseases and disorders, psychiatric diseases, musculoskeletal system, respiratory system, circulatory system, viral diseases, glaucoma, dental and oral diseases, headaches, migraine, obesity, hepatic treatments, cholesterol, blood pressure and rheumatic treatments; all of the foregoing excluding pharmaceutical preparations for the treatment and/or management of sleep disorders, narcolepsy, cataplexy, and/or excessive daytime sleepiness (EDS); veterinary preparation for treating digestive diseases and disorders, gynecological diseases and disorders, blood disorders, cancer, cardiovascular diseases, vascular diseases, gastrointestinal diseases, genitourinary diseases, immunologic diseases, infectious diseases, inflammatory diseases, metabolic diseases and disorders, musculoskeletal system, respiratory system, circulatory system, viral diseases, glaucoma, dental and oral diseases, headaches, migraine, obesity, hepatic treatments, cholesterol, blood pressure and rheumatic treatments; all of the foregoing excluding pharmaceutical preparations for the treatment and/or management of sleep disorders, narcolepsy, cataplexy, and/or excessive daytime sleepiness (EDS)


First Use Date in General

23rd Mar 2016

First Use Date in Commerce

26th Mar 2016

Class [035]
Advertising, Business & Retail Services


Sales promotion for others, business management assistance, business management consultancy and market research; presentation of goods by any means of communications for retailing purposes; commercial administration of the licensing of the goods and services of others; organisation of exhibitions, trade fairs or congresses for commercial or advertising purposes; all the aforesaid in this class relating to pharmaceutical businesses and for pharmaceutical preparations


First Use Date in General

23rd Mar 2016

First Use Date in Commerce

23rd Mar 2016

Mark Details


Serial Number

No 87091052

Mark Type

No Service Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Description of Design Search

The mark consists of the words "XIROMED" in stylized capital letters, the color blue appears in the upper section of the letter "X" and the color gray appears in the lower section of the letter "X" and in the letters "IROMED".

Legal History


Show more

Status DateAction Taken
28th Dec 2021REGISTERED-PRINCIPAL REGISTER
23rd Nov 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
22nd Nov 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
09th Nov 2021STATEMENT OF USE PROCESSING COMPLETE
06th Oct 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
23rd Sep 2021USE AMENDMENT FILED
23rd Sep 2021TEAS STATEMENT OF USE RECEIVED
14th Sep 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
14th Sep 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
14th Sep 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS